(Q41941241)

14 October 2017

Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways (English)

1 reference

14 October 2017

0 references

Jacques-Eric Gottenberg

3

object named as

Jacques-Eric Gottenberg

0 references

Corinne Miceli-Richard

2

object named as

Corinne Miceli-Richard

0 references

Xavier Mariette

9

object named as

Xavier Mariette

1 reference

14 October 2017

Marc Ittah

1

1 reference

14 October 2017

Corinne Miceli-Richard

2

1 reference

14 October 2017

Jérémie Sellam

4

1 reference

14 October 2017

Pierre Eid

5

1 reference

14 October 2017

Pierre Lebon

6

1 reference

14 October 2017

Coralie Pallier

7

1 reference

14 October 2017

Christine Lepajolec

8

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

European Journal of Immunology

14 October 2017

1 reference

14 October 2017

38

1 reference

14 October 2017

4

1 reference

14 October 2017

1058-1064

1 reference

Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines.

14 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200738013

1 reference

7 January 2021

Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

How Toll-like receptors signal: what we know and what we don't know

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Synthesis and release of B-lymphocyte stimulator from myeloid cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Persistent viral infection in primary Sjogren's syndrome: review and perspectives

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738013

7 January 2021

Identifiers

DOI

10.1002/EJI.200738013

1 reference

14 October 2017

1 reference